Clinical trial
Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial
NCT02749526 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- April 30, 2016
- Completion date
- December 31, 2018
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal